Tenon Medical, Inc. Releases The Results Of The First Post-clearance Clinical StudyMay 26, 2022 ⚊ 1 Min read ⚊ Views 72 ⚊ NEWS
Tenon Medical (NASDAQ: TNON) is a public medical device company that has developed a proprietary, FDA-cleared surgical implant system designed to optimize SI-Joint fixation/fusion surgery and corresponding outcomes. The company has raised over $30M in private and public equity and completed an IPO on 4/27/2022. The current market capitalization of Tenon Medical is over $450,000,000. Kal Mentak led Tenon Medical as CEO from 2015 to 2021 and through the pre-IPO stage.